Variant report
Variant | esv3340703 |
---|---|
Chromosome Location | chr4:158643396-158673727 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs531385559 | chr4:158643408-158643409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs113890058 | chr4:158643447-158643448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs61092344 | chr4:158643496-158643497 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs186513510 | chr4:158643497-158643498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs371952101 | chr4:158643504-158643505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs147701089 | chr4:158643520-158643521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs565505358 | chr4:158643565-158643566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189721523 | chr4:158643665-158643666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs182424973 | chr4:158643678-158643679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs571091190 | chr4:158643742-158643743 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188181791 | chr4:158643777-158643778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs76840320 | chr4:158643819-158643820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs142334943 | chr4:158643829-158643830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs7662753 | chr4:158643852-158643853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs554153998 | chr4:158643859-158643860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs147980600 | chr4:158643863-158643864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs112831069 | chr4:158643924-158643925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs146313221 | chr4:158643932-158643933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs546110364 | chr4:158643941-158643942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557618736 | chr4:158643992-158643993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs2345337 | chr4:158644016-158644017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs76219641 | chr4:158644036-158644037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs7662831 | chr4:158644054-158644055 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs573416867 | chr4:158644067-158644068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs4324591 | chr4:158644153-158644154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs540741589 | chr4:158644165-158644166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs386681143 | chr4:158644183-158644184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs72690991 | chr4:158644184-158644185 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs536455063 | chr4:158644191-158644192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs188185823 | chr4:158644196-158644197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs550912486 | chr4:158648249-158648250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs185711789 | chr4:158648268-158648269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs80311333 | chr4:158648389-158648390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs3937850 | chr4:158648415-158648416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs372178266 | chr4:158648429-158648430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs79494365 | chr4:158648459-158648460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs566928266 | chr4:158648462-158648463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs534320960 | chr4:158648555-158648556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs187449388 | chr4:158648556-158648557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs577357523 | chr4:158648566-158648567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs2087582 | chr4:158648628-158648629 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs1074653 | chr4:158648631-158648632 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs574692431 | chr4:158648682-158648683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs1074654 | chr4:158648689-158648690 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
45 | rs373888036 | chr4:158648720-158648721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs375886297 | chr4:158648727-158648728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs527479958 | chr4:158648729-158648730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs140766761 | chr4:158648731-158648732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs531697369 | chr4:158648761-158648762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs531261667 | chr4:158648769-158648770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 20409316 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 20164919 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Autism | 20841430 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:158643400-158644200 | Enhancers | HMEC | breast |
2 | chr4:158648200-158648600 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
3 | chr4:158648200-158648800 | Enhancers | Gastric | stomach |
4 | chr4:158648800-158649200 | Weak transcription | Gastric | stomach |
5 | chr4:158649200-158649600 | Enhancers | Gastric | stomach |
6 | chr4:158652600-158653000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr4:158656800-158657600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr4:158657000-158657400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr4:158659200-158659400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr4:158660600-158661000 | Enhancers | Muscle Satellite Cultured Cells | -- |
11 | chr4:158661000-158662600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
12 | chr4:158662600-158663400 | Enhancers | Muscle Satellite Cultured Cells | -- |
13 | chr4:158672800-158673600 | Enhancers | Muscle Satellite Cultured Cells | -- |